A Study to Investigate the Safety and Effectiveness of Different Doses of Sprifermin in Participants With Osteoarthritis of the Knee

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This was a multicenter, randomized, double-blind, placebo-controlled, parallel-group Phase 2 trial of Sprifermin administered intra-articularly in participants with primary osteoarthritis of the knee and Kellgren-Lawrence Grade 2 or 3. The trial was intended to investigate the efficacy and safety of different intra articular dosages of Sprifermin in these individuals.
Epistemonikos ID: 1beecd3bc2319c133029cf941e24d9907dcc253f
First added on: May 11, 2024